At the Hebrew University of Jerusalem, a $2.3 million investment has allowed Lumir Lab, a cannabinoid research lab, to set up on campus to study cannabinoid-based treatments. The investment came from Asana Bio Group Ltd., an Israeli company with a specialty in medical cannabis ventures. The lab will provide analyses, solutions, and clinical validation to companies operating in the medical cannabis industry. Lumir Lab will also create cannabinoid and terpene profiling as well as product formulations. The lab is headed by Lumír Ondřej Hanuš, a world-leading chemist and leading authority in the field of cannabis research. Lumír Hanuš along with William Anthony Devane became the first to identify and isolate Anandamide, the first endocannabinoid to be found in the human brain.